<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02375269</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-Nr. 2014-0458</org_study_id>
    <nct_id>NCT02375269</nct_id>
  </id_info>
  <brief_title>Effect of Remote Ischemic Preconditioning on Postoperative Complications in Visceral Surgery</brief_title>
  <acronym>RIPC</acronym>
  <official_title>A Randomized, Double- Blind Multicentric Study of the Effect of Remote Ischemic Preconditioning on Postoperative Complications in Patients Undergoing Major Minimal and Open Visceral Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Remote Ischemic Preconditioning (RIPC) is mediated by intermittent brief episodes (5-10
      minutes) of short ischemia in a limb (i.e. arm), followed by reperfusion. For this purpose in
      3-4 cycles, a tourniquet is insufflated to suprasystolic pressure levels for 5 minutes and
      deflated for 5 minutes afterwards. The ischemic episodes are known to stimulate platelets and
      factors platelet dependent factors such as Serotonin and VEGF. These humoral factors have a
      systemic effect and have the potential to protect target organs (i.e. heart, kidney, liver)
      remote to the ischemic limb.

      The purpose of this randomized controlled study is to investigate the influence and impact of
      RIPC on postoperative complications in patients undergoing visceral surgery
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Complications will be assessed by Comprehensive Complication Index and Dindo Clavien Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection composite parameters</measure>
    <time_frame>30 days</time_frame>
    <description>CRP, Procalcitonin, Leucocytes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">526</enrollment>
  <condition>Postoperative Complication</condition>
  <arm_group>
    <arm_group_label>RIPC (Remote Ischemic Preconditioning)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoperatively in the operation theater a tourniquet will be applied to the left arm and RIPC will performed. Therefore the tourniquet will be insufflated to suprasystolic pressure levels for 5 minutes, followed by 5 minutes reperfusion (deflated). Three cycles are planned. Duration of the procedure is 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Preoperatively in the operation theater a tourniquet will be applied to the left arm. The tourniquet will not be insufflated. The tourniquet will be removed after 30 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RIPC with a tourniquet</intervention_name>
    <arm_group_label>RIPC (Remote Ischemic Preconditioning)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years

          -  Undergoing major visceral surgery

        Exclusion Criteria:

          -  &lt; 18 years

          -  Pregnancy

          -  Signs of Infection/Inflammation on upper limb

          -  Shunt

          -  Medical history of axillary lymph node dissection

          -  Signs of malperfusion of upper limb (i.e. Allen Test)

          -  Missing informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre- Alain Clavien, MD, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Surgery, Swiss HPB and Transplant Surgery, University Hospital Zurich, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patryk Kambakamba, MD</last_name>
    <phone>0442551111</phone>
    <email>patryk.kambakamba@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christian Oberkofler, MD</last_name>
    <phone>0442551111</phone>
    <email>christian.oberkofler@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Surgery, Swiss HPB and Transplant Surgery, University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patryk Kambakamba, MD</last_name>
      <phone>044255111</phone>
      <email>patryk.kambakamba@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Christian Oberkofler, MD</last_name>
      <phone>044255111</phone>
      <email>christian.oberkofler@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Oberkofler CE, Limani P, Jang JH, Rickenbacher A, Lehmann K, Raptis DA, Ungethuem U, Tian Y, Grabliauskaite K, Humar R, Graf R, Humar B, Clavien PA. Systemic protection through remote ischemic preconditioning is spread by platelet-dependent signaling in mice. Hepatology. 2014 Oct;60(4):1409-17. doi: 10.1002/hep.27089. Epub 2014 Aug 13.</citation>
    <PMID>24700614</PMID>
  </reference>
  <reference>
    <citation>Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuh√§user M, Peters J, Jakob H, Heusch G. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013 Aug 17;382(9892):597-604. doi: 10.1016/S0140-6736(13)61450-6. Erratum in: Lancet. 2013 Sep 14;382(9896):940.</citation>
    <PMID>23953384</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2015</study_first_submitted>
  <study_first_submitted_qc>February 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2015</study_first_posted>
  <last_update_submitted>February 27, 2015</last_update_submitted>
  <last_update_submitted_qc>February 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Visceral Surgery</keyword>
  <keyword>Comprehensive Complication Index</keyword>
  <keyword>Patient undergoing abdominal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

